Prosecution Insights
Last updated: May 29, 2026

Examiner: MI, QIUWEN

Tech Center 1600 • Art Units: 1655 1657

This examiner grants 68% of resolved cases

Performance Statistics

68.2%
Allow Rate
+8.2% vs TC avg
1,612
Total Applications
+49.9%
Interview Lift
930
Avg Prosecution Days
Based on 1577 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%
§101 Eligibility
15.5%
§102 Novelty
72.7%
§103 Obviousness
7.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18009096 METHODS FOR PRODUCING A (THREE DIMENSIONAL) NEURAL TISSUE Non-Final OA TECHNISCHE UNIVERSITEIT EINDHOVEN
18135795 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE Non-Final OA UNIVERSITY OF MIAMI
18701070 THERAPEUTIC AND PREVENTIVE COMPOSITIONS Non-Final OA Cellnutrition Ltd
18696920 METHOD OF TREATING CANCER Non-Final OA Native Ingredients and Health Research Organisation Pty Ltd
18619650 HAIR GROWTH COMPOSITION AND METHODS THEREOF Non-Final OA Chelsea Ashira LLC
18611998 COSMETIC COMPOSITIONS COMPRISING A CACTUS FLOWER EXTRACT COMPLEX Non-Final OA SKG Beauty Holdings, Inc
18681081 NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION Non-Final OA N.V. Nutricia
18691629 TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFERTILITY Non-Final OA CHEMEX GLOBAL
18293854 ARTHROPOD CONTROL PRODUCTS Non-Final OA Firmenich SA
18577877 COMPOSITION FOR IMPROVING UNIDENTIFIED COMPLAINTS, DEPRESSION, IMPAIRED CONCENTRATION, DECREASED MOTIVATION FOR SOCIALIZATION AND DAILY ACTIVITIES, AUTONOMIC NERVOUS SYSTEM DISORDERS, PAIN, CONTROL AND POOR SLEEP QUALITY ASSOCIATED WITH MENSTRUATION. Non-Final OA Tokiwa Phytochemical Co., Ltd.
18543830 TURMERIC OIL ESSENTIAL-OIL BISABOLENE SESQUITERPENOIDS IN THE TREATMENT OF NON-NEURODEGENERATIVE DISEASES Non-Final OA UNIVERSIDAD DE CUENCA
18571123 NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS Final Rejection Sunregen Healthcare AG
18538894 EXTRACTION OF COMPOUNDS WITH BETA-CARYOPHYLLENE, COMPOSITIONS AND USES THEREOF Non-Final OA Synaptix Inc.
18534272 EDIBLE CANNABIS PLANT POWDER Final Rejection The Hemp Tea Company, LLC
18510162 COMPOSITIONS FOR MITIGATING THE EFFECTS OF ALCOHOL CONSUMPTION AND METHODS RELATED THERETO Non-Final OA LIFTED BEVERAGES CORPORATION
18264918 THERAPEUTIC COMPOSITION BASED ON DHODH-INHIBITING NEUROLAENA LEAVES FOR THE TREATMENT OF RNA VIRUS INFECTIONS Non-Final OA PHYTOBOKAZ
18350891 Enhanced Mediterranean Diet-Based Nutritional Compositions And Methods Non-Final OA DailyColors Health Inc.
18020323 Bee Product Extracts, Methods of Production, and Uses Thereof Non-Final OA Quantum Technologies Limited
18156364 THERAPEUTIC HERBAL COMPOSITIONS FOR IMPROVING LIVER HEALTH Non-Final OA KARALLIEF, INC.
17918751 USE OF A POLAR EXTRACT OF SKELETONEMA IN PHOTODYNAMIC THERAPY Non-Final OA UNIVERSITÉ DE LA ROCHELLE

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month